A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes

scientific article published on 09 October 2013

A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/IJN.S47749
P932PMC publication ID3797616
P698PubMed publication ID24143089
P5875ResearchGate publication ID258062329

P2093author name stringShinji Takeoka
Tianshu Li
P2860cites workUltrasound triggered release of cisplatin from liposomes in murine tumorsQ28238830
Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivoQ33369240
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingQ34268743
Liposomes to target the lymphatics by subcutaneous administrationQ34328471
Shear-stress sensitive lenticular vesicles for targeted drug deliveryQ58828277
Long-circulating (sterically stabilized) liposomes for targeted drug deliveryQ72755730
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft modelQ73574280
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodesQ74450929
Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomesQ80800309
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI).Q34506108
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activitiesQ35058921
pH-sensitive liposomes: acid-induced liposome fusionQ36255409
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesQ36319725
The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II studyQ36611388
Redox-triggered contents release from liposomes.Q36990677
Liposomes in ultrasonic drug and gene deliveryQ37163645
Reduction-sensitive polymers and bioconjugates for biomedical applicationsQ37387864
Exploiting cell surface thiols to enhance cellular uptake.Q39662191
Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivoQ39782879
Photoresponsive liposomal nanohybrid cerasomesQ39975143
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisQ40632272
Targeted drug delivery to tumors: myths, reality and possibilityQ40868797
Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipidsQ42828524
Cell-surface thiols affect cell entry of disulfide-conjugated peptides.Q46031651
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid doseQ47301856
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectdrug deliveryQ1392806
P304page(s)3855-3866
P577publication date2013-10-09
P1433published inInternational Journal of NanomedicineQ6051502
P1476titleA novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
P478volume8

Reverse relations

cites work (P2860)
Q41139938Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
Q40520681Enhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transport
Q47135091Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
Q41935955Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
Q99403564Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC

Search more.